Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-09-27FDA Approved: OTULFI — Original Application (Fresenius Kabi USA, LLC)
FDA approved OTULFI (ustekinumab-aauz) from Fresenius Kabi USA, LLC, as an original application. OTULFI is a monoclonal antibody targeting I…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Acupuncture for Symptom Relief in Adults with Mild to Moderate Ulcerative Colitis [NA]
This clinical trial registry entry, sponsored by Guang'anmen Hospital of China Academy of Chinese Medical Sciences, investigates acupuncture…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Vedolizumab in Pediatric Ulcerative Colitis- Comparison With Infliximab [Phase 3]
Phase 3 pediatric ulcerative colitis trial comparing vedolizumab with infliximab is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis [Phase 2]
Phase 2 trial update evaluating the long-term safety and efficacy of deucravacitinib in participants with Crohn's disease or ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis [Phase 2]
Phase 2 study evaluating erythrocyte-mediated delivery of dexamethasone 21-phosphate for steroid-dependent ulcerative colitis has completed …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis [Phase 4]
This document provides an update on a Phase 4 clinical trial evaluating the combination of the probiotic VSL#3 with Vedolizumab for moderate…
-
CLINICAL_TRIALS trial_result · 2024-09-23Clinical Trial Update: This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.
This clinical trial update describes a completed real-world study in Finland evaluating the use of tofacitinib for ulcerative colitis and no…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan [Phase 2, Phase 3]
A clinical trial in Amman, Jordan is assessing the effect of probiotic supplementation on the immune system in patients with Ulcerative Coli…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: ENhanced Recovery in CHildren Undergoing Surgery [Phase 3]
A Phase 3 clinical trial assessing Enhanced Recovery in children undergoing surgery for inflammatory bowel disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Digital Behavioral Interventions in Inflammatory Bowel Disease [NA]
A completed clinical trial conducted at Montefiore Medical Center evaluated digital behavioral interventions for patients with Crohn's disea…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients [Phase 2]
Phase 2 clinical trial evaluating FAPi-PET imaging of in vivo fibrosis in inflammatory bowel disease patients is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effect of Procyanidins in Leaky Gut Repairing in IBD [NA]
A University of Padova-sponsored clinical trial evaluating whether procyanidins can repair leaky gut in patients with ulcerative colitis in …
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Assess Effectiveness of Therapy Timely Adjustment Based on Self-monitoring in Patients Suffering From Mild-to-moderate Ulcerative Colitis (OPTIMISE Study) [NA]
Clinical trial update for the OPTIMISE study evaluating whether timely therapy adjustments guided by self-monitoring improve outcomes in mil…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Infliximab Proactive Drug Monitoring in the Pediatric IBD Population
Clinical trial update on proactive drug monitoring with infliximab in pediatric inflammatory bowel disease. The study status is ACTIVE_NOT_R…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery
A clinical trial update examines energy expenditure in patients with ulcerative colitis undergoing surgery. The study is sponsored by Evange…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effectiveness and Tolerance of IV vs SC Biological Drugs in Gastrointestinal Diseases
A clinical trial comparing intravenous versus subcutaneous administration of biological drugs for inflammatory bowel diseases is currently r…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Unravelling Intestinal Fibrosis in Ulcerative Colitis [Phase 2, Phase 3]
Phase 2/3 clinical trial assessing a fibroblast activation protein inhibitor for intestinal fibrosis in ulcerative colitis, currently recrui…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study [Phase 4]
ULTRAZ, a Phase 4 trial evaluating leukocyte trafficking after Zeposia (ozanimod) treatment in ulcerative colitis, has been withdrawn.
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Subcutaneous Interval Lengthening of Vedolizumab for Economic Research [Phase 4]
A Phase 4 clinical trial is evaluating longer-interval subcutaneous administrations of vedolizumab for economic research in inflammatory bow…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Parasitic Infections and Ulcerative Colitis: Combining Anti-parasitic and Immunomodulatory Treatments May Achieve Remission [NA]
A completed clinical trial from Benha University explored whether combining anti-parasitic therapy with immunomodulatory treatment could ind…
-
CLINICAL_TRIALS trial_result · 2024-09-03Clinical Trial Update: Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients
Results from a Korea post-marketing surveillance study of Xeljanz (tofacitinib) in Ulcerative Colitis patients have completed and results we…
-
FDA approval · 2024-08-26FDA Approved: ADALIMUMAB-RYVK — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for ADALIMUMAB-RYVK, a biosimilar to adalimumab, submitted by Quallent Pharmaceuticals Health LL…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Utility of Low Intensity Pulsed Ultrasound Stimulation (LIPUS) to Modulate the Release of Mediators Capable of Reflecting the Inflammatory State in the Affected Colonic Tract of Ulcerative Colitis Patients [NA]
The document describes a clinical trial evaluating low-intensity pulsed ultrasound stimulation to modulate inflammatory mediators in the col…
-
FDA approval · 2024-08-22FDA Approved: MESALAMINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for mesalamine filed by Actavis Pharma, Inc., resulting in an approved updated label and/or form…
-
FDA approval · 2024-08-22FDA Approved: MESALAMINE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved Ingenus Pharmaceuticals, LLC's original application for mesalamine (generic mesalamine).